MAIA Biotechnology Boosts CEO Jeffrey Himmelreich’s Salary
Company Announcements

MAIA Biotechnology Boosts CEO Jeffrey Himmelreich’s Salary

MAIA Biotechnology, Inc. (MAIA) just unveiled an announcement.

Starting April 1, 2024, Jeffrey Himmelreich’s employment agreement will see his base salary raised to $250,000, with his target annual bonus climbing to 25% of his base salary, reflecting a substantial increase in his compensation package.

Find detailed analytics on MAIA stock on TipRanks’ Stock Analysis page.

Related Articles
TipRanks Auto-Generated NewsdeskMAIA Biotechnology Reveals Promising Phase 2 Trial Results
TipRanks Auto-Generated NewsdeskMAIA Biotechnology Advances with Clinical Trials and Partnerships
TheFlyMAIA Biotechnology’s THIO shows positive survival data in lung cancer study
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App